Fasting Triglycerides: What This Test Actually Measures

What Fasting Triglycerides Actually Measure

Triglycerides are the main storage form of fat in your body. After you eat, your digestive system breaks dietary fat and excess carbohydrates into fatty acids, which are then reassembled into triglyceride molecules and packaged inside particles called very-low-density lipoproteins (VLDL). These particles travel through your bloodstream to deliver energy to muscles and organs. Whatever your body does not immediately use gets stored in adipose tissue.

A fasting triglyceride test captures the concentration of those VLDL-packaged triglycerides that remain in circulation after you have not eaten for 8 to 12 hours. That fasting window matters because a meal can temporarily spike triglycerides by 20 to 50 mg/dL or more, which would make your result uninterpretable. Fasting lipid panel guidelines from the National Heart, Lung, and Blood Institute confirm that fasting is the standard for cardiovascular risk classification.

Why the Test Is Ordered

Fasting triglycerides are almost always part of a standard lipid panel that also includes total cholesterol, LDL, and HDL. Your clinician uses the triglyceride number to:

• Assess cardiovascular and metabolic risk
• Screen for metabolic syndrome (which requires a triglyceride level of ≥150 mg/dL as one of its five diagnostic criteria, per the ATP III/AHA/NHLBI definition)
• Estimate non-HDL cholesterol and remnant-particle burden, both of which are increasingly recognized as independent cardiovascular risk markers in women
• Identify severe hypertriglyceridemia (≥500 mg/dL) that raises the risk of acute pancreatitis

What Triglycerides Are Not Measuring

The fasting triglyceride number does not directly measure LDL particle size, arterial plaque, or insulin levels. It gives you a snapshot of circulating fat, not a complete picture of cardiovascular risk on its own.

Normal Ranges, and Why They Are Not One-Size-Fits-All for Women

The American Heart Association and National Heart, Lung, and Blood Institute define the following fasting triglyceride categories:

| Category | Fasting Triglyceride Level | |---|---| | Normal | <150 mg/dL | | Borderline high | 150 to 199 mg/dL | | High | 200 to 499 mg/dL | | Very high | ≥500 mg/dL |

These cut-offs apply to adults of all sexes, but women's baseline triglyceride levels tend to run slightly lower than men's during the reproductive years. Data from the National Health and Nutrition Examination Survey showed that premenopausal women had median fasting triglyceride levels approximately 20 to 30 mg/dL lower than age-matched men, a pattern documented in this NHANES-based analysis. This protective gap narrows significantly after menopause.

Interpreting a Borderline High Result (150 to 199 mg/dL)

A borderline result warrants attention, especially if you also have low HDL (below 50 mg/dL in women), elevated blood pressure, elevated fasting glucose, or increased waist circumference. Those five factors together define metabolic syndrome, which affects roughly one in three American women. A single borderline triglyceride number alone is not a diagnosis, but it is a signal worth investigating rather than dismissing.

When Your Lab Report Looks Different from These Numbers

Some labs still report triglycerides in mmol/L rather than mg/dL. To convert: divide mg/dL by 88.6 (or multiply mmol/L by 88.6 to go the other direction). A result of 1.7 mmol/L equals approximately 150 mg/dL.

How Hormones Change Your Triglyceride Results: A Life-Stage Guide

This is where the female-specific physiology becomes essential. Triglyceride metabolism shifts substantially across your hormonal life.

Reproductive Years (Roughly Ages 18 to 40)

During your reproductive years, estrogen generally supports lower triglyceride levels by increasing lipoprotein lipase activity, the enzyme that clears triglycerides from the bloodstream. This is one reason cardiovascular risk is statistically lower in premenopausal women compared with age-matched men. The protection is real, but it is not absolute, and it does not protect against the effects of a high-sugar diet, insulin resistance, or conditions like PCOS.

PCOS and Triglycerides

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive-age women, affecting 6 to 13 percent of women globally. Insulin resistance is central to most PCOS phenotypes, and insulin resistance directly drives triglyceride overproduction in the liver. Women with PCOS are more likely to have fasting triglycerides in the borderline-to-high range even when their BMI is in the normal category. A 2020 meta-analysis in Fertility and Sterility confirmed that women with PCOS had significantly higher fasting triglycerides compared with controls after adjusting for BMI. If you have PCOS, your clinician should check a fasting lipid panel at diagnosis and repeat it annually, not just every four to six years.

Trying to Conceive

If you are working with a reproductive endocrinologist or fertility specialist, your lipid panel may be part of your preconception workup. Severe hypertriglyceridemia (≥500 mg/dL) is associated with reduced egg quality and poorer IVF outcomes in some studies, though the data in this specific area are still limited and extrapolated from small cohorts.

Pregnancy

Triglycerides rise in pregnancy. This is physiologically normal and expected. By the third trimester, fasting triglycerides in a healthy pregnancy may be two to three times the prepregnancy level, as documented in longitudinal pregnancy cohort data. The liver produces more VLDL to supply the placenta and fetus with fatty acids. Standard non-pregnant reference ranges do not apply during pregnancy.

The concern arises when a woman enters pregnancy with already-elevated triglycerides. Severe hypertriglyceridemia in pregnancy (generally defined as fasting triglycerides above 1000 mg/dL) carries a real risk of gestational pancreatitis, which can be life-threatening for both mother and baby. Women with familial hypertriglyceridemia, PCOS, or pre-existing metabolic syndrome should have their triglycerides checked early in pregnancy and monitored through each trimester.

Fibrates (the main drug class used to treat very high triglycerides) are generally avoided in pregnancy, particularly in the first trimester, due to limited safety data and potential teratogenicity. Omega-3 fatty acid supplements are sometimes used cautiously in the second and third trimesters under specialist supervision, though high-dose prescription formulations (icosapentaenoic acid, such as Vascepa) have not been adequately studied in pregnant women. Dietary management is the primary approach.

Postpartum and Lactation

Triglycerides typically return toward baseline within 6 to 12 weeks postpartum. Breastfeeding may modestly support lipid normalization. If your triglycerides were significantly elevated before or during pregnancy, a repeat fasting lipid panel at your postpartum visit (6 to 8 weeks) is appropriate to confirm they are trending down.

Perimenopause

Perimenopause, typically beginning in the mid-40s, is a period of hormonal volatility. Estrogen levels fluctuate widely before declining, and this volatility correlates with changes in lipid metabolism. Fasting triglycerides often begin to climb during perimenopause even before a woman's last period. A longitudinal analysis from the SWAN study (Study of Women's Health Across the Nation) showed that triglycerides increased significantly in the years surrounding menopause, independent of aging and BMI changes.

If you are in perimenopause and your triglycerides have crept up compared with previous labs, this is not just "getting older." It reflects the real metabolic consequences of fluctuating and declining estrogen, and it warrants dietary and lifestyle attention now, before the numbers become harder to manage.

Postmenopause

After menopause, the estrogen-mediated protection on triglyceride clearance is substantially reduced. Postmenopausal women, on average, have higher fasting triglycerides than premenopausal women of the same age. Data from the Women's Health Initiative showed that postmenopausal women not using hormone therapy had significantly higher triglyceride levels compared with premenopausal controls, and that oral estrogen-containing hormone therapy (but not transdermal estradiol) can raise triglycerides further by increasing hepatic VLDL production. This is a clinically important distinction: if you have borderline-to-high triglycerides and are considering hormone therapy, transdermal estradiol is generally preferred over oral estrogen for its neutral-to-favorable effect on triglycerides and coagulation risk, per The Menopause Society's 2023 position statement.

What High Fasting Triglycerides Actually Mean for Your Health

High fasting triglycerides rarely cause symptoms on their own. The clinical significance is in what they signal about your broader metabolic state.

Metabolic Syndrome and Insulin Resistance

The most common reason for chronically elevated triglycerides is insulin resistance, a state in which your cells respond poorly to insulin and your liver compensates by overproducing VLDL. The AHA/NHLBI definition of metabolic syndrome requires three of five criteria; elevated triglycerides (≥150 mg/dL) is one of them. Women with metabolic syndrome have a two- to fourfold increased risk of cardiovascular disease compared with women without it.

MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)

Formerly called non-alcoholic fatty liver disease (NAFLD), MASLD is now recognized as the hepatic manifestation of insulin resistance and metabolic syndrome. High fasting triglycerides are both a marker and a contributor to excess liver fat accumulation. A 2023 multinational Delphi consensus renamed the condition MASLD and defined metabolic criteria that include elevated triglycerides. Women with PCOS are at particularly elevated MASLD risk.

Cardiovascular Risk in Women

Hypertriglyceridemia contributes to cardiovascular risk partly through its association with small, dense LDL particles and low HDL, but also through a direct atherogenic effect of triglyceride-rich remnant lipoproteins. A 2021 analysis published in JAMA Cardiology found that non-fasting triglycerides predicted cardiovascular events in women independently of LDL cholesterol, supporting the case for routine triglyceride monitoring in women's cardiovascular risk assessment.

When Triglycerides Hit 500 mg/dL or Higher

At very high levels (≥500 mg/dL), triglycerides themselves cause harm: the high concentration of chylomicrons and VLDL overwhelms the pancreatic enzyme system and can trigger acute pancreatitis. This is a medical emergency. Women with familial hypertriglyceridemia, those who are pregnant, or those taking medications that raise triglycerides (such as oral estrogen, certain antipsychotics, or isotretinoin) are at elevated risk of reaching these thresholds.

What Causes High Fasting Triglycerides in Women

Dietary Drivers

• High intake of refined carbohydrates and added sugars (fructose in particular is a potent hepatic triglyceride driver)
• Excess alcohol, even moderate amounts in susceptible individuals
• Very low fat diets paradoxically increase triglycerides in some women because carbohydrates replace fat calories
• Rapid weight gain

Hormonal and Condition-Related Causes

• PCOS (via insulin resistance)
• Hypothyroidism (thyroid hormone regulates lipoprotein lipase; untreated hypothyroidism raises triglycerides)
• Type 2 diabetes and prediabetes
• Oral estrogen-containing hormone therapy or combined oral contraceptives, particularly in women with baseline elevated triglycerides
• Pregnancy (physiological, but monitored)
• Familial hypertriglyceridemia (genetic)

Medication-Related Causes

• Oral estrogens (first-pass hepatic effect increases VLDL synthesis)
• Corticosteroids
• Certain atypical antipsychotics (olanzapine, quetiapine, clozapine)
• Isotretinoin
• Some HIV antiretroviral medications
• Beta-blockers (modest effect)

How to Lower High Fasting Triglycerides

Lifestyle changes produce meaningful reductions in fasting triglycerides, often faster than they lower LDL.

Dietary Changes with the Strongest Evidence

Cutting added sugars and refined starches is the single most effective dietary intervention. A randomized controlled trial by Stanhope et al. Published in the Journal of Clinical Investigation showed that consuming 25 percent of daily calories as fructose for 10 weeks raised fasting triglycerides by approximately 10 mg/dL and increased de novo lipogenesis (liver fat production) significantly compared with glucose. The practical takeaway: sugar-sweetened beverages, fruit juice, and ultra-processed sweets have an outsized effect on your triglyceride number.

Increasing omega-3 fatty acids from fatty fish (salmon, mackerel, sardines) or prescription-grade omega-3 supplements can reduce triglycerides by 20 to 30 percent at doses of 3 to 4 grams of EPA plus DHA per day, per a meta-analysis in JAMA. Over-the-counter fish oil supplements vary widely in purity and actual EPA/DHA content; prescription formulations (icosapentaenoic acid, Vascepa; or EPA+DHA, Lovaza) deliver consistent doses.

Exercise

Aerobic exercise is independently effective. Moderate-intensity exercise on most days of the week can lower fasting triglycerides by 10 to 20 percent over 12 weeks, according to a Cochrane review of exercise interventions on lipids. Resistance training adds incremental benefit, particularly in women with insulin resistance and PCOS.

Weight Management

Each 5 to 10 percent reduction in body weight is associated with approximately a 20 percent decrease in fasting triglycerides, based on data reviewed in Endocrine Practice. GLP-1 receptor agonists (semaglutide, tirzepatide) produce significant triglyceride reductions as part of their broader metabolic effects, partly through weight loss and partly through direct hepatic mechanisms. If you are working with a WomanRx clinician on GLP-1 therapy, expect to see your triglycerides improve alongside other metabolic markers within 12 to 16 weeks.

Medications for High Triglycerides

When lifestyle changes are insufficient, particularly at triglyceride levels above 500 mg/dL, medications are used:

• Fibrates (fenofibrate, gemfibrozil): reduce triglycerides by 30 to 50 percent; first-line for very high triglycerides
• Prescription omega-3s (Vascepa/icosapentaenoic acid, Lovaza): reduce triglycerides by 20 to 45 percent; Vascepa has demonstrated cardiovascular event reduction in the REDUCE-IT trial
• Niacin: effective but largely fallen out of favor due to side effects and lack of cardiovascular event reduction in trials like AIM-HIGH

A practical clinical decision framework for women with elevated fasting triglycerides, developed by the WomanRx editorial board:

Step 1. Rule out secondary causes first: check TSH (hypothyroidism), fasting glucose and HbA1c (diabetes/prediabetes), review current medications including oral contraceptives and hormone therapy.

Step 2. Stage by life phase. Premenopausal with PCOS? Insulin sensitization (metformin, inositol, lifestyle) should be the first target. Perimenopausal with rising triglycerides and considering hormone therapy? Choose transdermal estradiol over oral estrogen. Postmenopausal with metabolic syndrome? Annual lipid panels are appropriate, not every 4 to 6 years.

Step 3. Set a treatment target. For most women, the goal is fasting triglycerides below 150 mg/dL. For women with established cardiovascular disease or metabolic syndrome, below 100 mg/dL is a reasonable aspirational target, though guidelines do not yet specify a hard target for triglycerides the way they do for LDL.

Step 4. Recheck in 8 to 12 weeks after any intervention, dietary or pharmacological, to confirm response before escalating therapy.

Pregnancy, Lactation, and Triglyceride-Lowering Medications

This section is required for completeness because some women reading this may be pregnant, planning pregnancy, or breastfeeding while managing high triglycerides.

Fibrates in pregnancy: Fenofibrate and gemfibrozil are generally avoided, particularly in the first trimester. Animal data show some evidence of fetal harm, and human safety data are insufficient. They are classified as FDA Pregnancy Category C (under the old system) and are not recommended by ACOG unless the risk of pancreatitis from uncontrolled very high triglycerides clearly outweighs the medication risk, a decision made only in specialist settings.

Statins in pregnancy: Statins are contraindicated in pregnancy. They are mentioned here because some women with high triglycerides are also on statins for LDL management. Discontinue statins at least 1 month before attempting conception and do not restart until breastfeeding is complete, per current FDA labeling and ACOG guidance.

Prescription omega-3s in pregnancy: High-dose EPA/DHA supplementation (as in Vascepa or Lovaza) has not been adequately studied in pregnant women at the doses used for triglyceride lowering. Dietary omega-3s from low-mercury fish are safe and encouraged in pregnancy. The ACOG recommendation for omega-3 intake in pregnancy supports at least 2 servings of low-mercury fatty fish per week, which provides approximately 300 to 500 mg EPA+DHA per day, far below the therapeutic triglyceride-lowering doses.

Lactation: Fibrates transfer into breast milk in animal studies; human data are absent. Fibrates are generally not recommended during breastfeeding. Dietary management and omega-3-rich foods are the preferred approach.

Contraception note: Women on fibrates who are of reproductive age should use reliable contraception if pregnancy is not planned, given the insufficient pregnancy safety data.

Who Should Be Tested, and How Often

The USPSTF recommends lipid screening for women aged 45 and older, and for younger women with increased cardiovascular risk. In clinical practice, testing is appropriate at any age if you have:

• PCOS
• Family history of premature cardiovascular disease or familial hypertriglyceridemia
• Diabetes or prediabetes
• Obesity (BMI above 30)
• Thyroid disease
• Started oral estrogen-containing contraception or hormone therapy

For women with normal results and no risk factors, retesting every 4 to 6 years is reasonable. Women with PCOS, metabolic syndrome, or established cardiovascular risk factors should test annually.

What a Low Fasting Triglyceride Level Means

Very low fasting triglycerides (below 50 mg/dL) are rarely a clinical concern on their own. They can occur with very low fat diets, hyperthyroidism, or, occasionally, malabsorption syndromes. If your level is very low and you feel well, it generally requires no intervention. If it is accompanied by symptoms of malnutrition, unexplained weight loss, or very high HDL (above 100 mg/dL), your clinician may investigate further for thyroid overactivity or a malabsorptive condition.